These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1838416)

  • 21. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B; Dimling J; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.
    Egorin MJ; Conley BA; Forrest A; Zuhowski EG; Sinibaldi V; Van Echo DA
    Cancer Res; 1987 Nov; 47(22):6104-10. PubMed ID: 2959359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
    Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
    J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.
    Skillings J; Cripps C; Eisenhauer E; Pater J; Verma S; Walde D
    Invest New Drugs; 1991 Feb; 9(1):79-82. PubMed ID: 1827434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study.
    Vance RB; Crowley JJ; Macdonald JS; Ahmann FR
    Invest New Drugs; 1991 Feb; 9(1):73-5. PubMed ID: 1851143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
    Dodion P; Sanders C; Rombaut W; Rozencweig M; Kitt MM; Kenis Y; Klastersky J
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):245-9. PubMed ID: 2940092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
    Sessa C; Kaye SB; Renard J; ten Bokkel Huinink W; Cavalli F
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of menogaril in patients with advanced hypernephroma.
    Long HJ; Hauge MD; Therneau TM; Buckner JC; Frytak S; Hahn RG
    Invest New Drugs; 1991 Aug; 9(3):261-2. PubMed ID: 1838363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
    LONG HJ; Wieand HS; Foley JF; Niedringhaus RD; Laurie JA; Morton RF; Goldberg RM; Mailliard JA; Malkasian GD; Edmonson JH
    Invest New Drugs; 1991 Nov; 9(4):349-51. PubMed ID: 1839536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of menogaril in advanced colorectal cancer.
    Holdener EE; ten Bokkel Huinink WW; Decoster G; Ludwig C; Renard G; Pinedo HM
    Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.
    Stewart DJ; Eisenhauer EA; Skillings J; Pritchard KI; Buckman R; VAndenberg T; Verma S; Aitken S; Norris B
    Ann Oncol; 1992 Mar; 3(3):201-4. PubMed ID: 1534021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of oral menogaril administered daily for 14 consecutive days.
    Stewart DJ; Aitken SE; Verma S; Maroun JA; Robillard L; Touchie M; Prosser IA; Earhart R
    Ann Oncol; 1992 May; 3(5):401-3. PubMed ID: 1535508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
    Adams EG; Bhuyan BK
    Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I study of oral menogaril administered on a once weekly schedule.
    Stewart DJ; Verma S; Maroun JA; Robillard L; Earhart RH
    Invest New Drugs; 1990 Feb; 8(1):43-52. PubMed ID: 2140564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I and pharmacokinetic study of menogaril administered as a 72-hour continuous i.v. infusion.
    Long HJ; Powis G; Schutt AJ; Moertel CG
    Cancer Treat Rep; 1987 Jun; 71(6):593-8. PubMed ID: 2953414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
    Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
    Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
    Ratain MJ; Schilsky RL
    Cancer Res; 1986 Sep; 46(9):4874. PubMed ID: 2942243
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
    Sugimoto Y; Matsuo K; Takeda S; Yamada Y; Tsukagoshi S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):353-8. PubMed ID: 2138003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
    Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J
    Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer.
    Boven E; Schlüper HM; Erkelens CA; Pinedo HM
    Eur J Cancer; 1990; 26(9):983-6. PubMed ID: 2149026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.